Form 8-K - Current report:
SEC Accession No. 0001104659-26-066956
Filing Date
2026-05-27
Accepted
2026-05-27 16:15:26
Documents
11
Period of Report
2026-05-21
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K pasg-20260521x8k.htm   iXBRL 8-K 37119
  Complete submission text file 0001104659-26-066956.txt   148660

Data Files

Seq Description Document Type Size
2 EX-101.SCH pasg-20260521.xsd EX-101.SCH 2685
3 EX-101.LAB pasg-20260521_lab.xml EX-101.LAB 15924
4 EX-101.PRE pasg-20260521_pre.xml EX-101.PRE 10061
14 EXTRACTED XBRL INSTANCE DOCUMENT pasg-20260521x8k_htm.xml XML 4894
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 261026355
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)